Los Angeles, CA, USA. 22nd Oct, 2015. Andrew Left, owner and founder of Citron Research, stands for a portrait in Los Angeles, California, U.S., on Thursday, Oct. 22, 2015. In January 2021,
Citron Research: Why You Should Know Who They Are - Warrior Trading
U.S. Short Seller Andrew Left Loses Appeal in Hong Kong - WSJ
Famed short seller tells MarketWatch why he's betting against Tesla's 'casino' - MarketWatch
Former Tesla short seller Citron Research one of 30 firms caught in DOJ probe
Short-seller Andrew Left launches second appeal against trading ban in Hong Kong | South China Morning Post
Federal agents raided home of Andrew Left in 2021: report
Tesla Inc chief Elon Musk faces lawsuit from short-seller Andrew Left of Citron Research
Another Lie: Citron Research Continues as a Short Activist Firm | by Andrew Kamal | QuantPortal | Medium
Citron Research, short seller caught up in GameStop, is pivoting
FBI Seized Computers From Short Seller Andrew Left, the founder of Citron Research. DOJ Probe Looks At 30 Short-Seller Firms and it's Allies, including Kerrisdale Cap. : r/MMAT
Citron to Stop Publishing Short-Seller Research After GameStop Squeeze
Short seller Citron switches to long position on Tesla shares
Citron Research, short seller caught up in GameStop, is pivoting
CGTN America - Short-seller and CEO of Citron Research,... | Facebook
In Major DOJ Probe, FBI Seized Computers of Short Seller Andrew Left of Citron Research in 2021 - SWFI
Short-seller Citron changes course, adjusts to new reality | Reuters
Los Angeles, CA, USA. 22nd Oct, 2015. Andrew Left, owner and founder of Citron Research, stands for a portrait in Los Angeles, California, U.S., on Thursday, Oct. 22, 2015. In January 2021,
I Would Short Ether Before Bitcoin, Says Citron's Andrew Left - CoinDesk
Citron's Andrew Left Defends His China Record
Federal agents raided home of Andrew Left in 2021: report
Short-seller Andrew Left to seek investor money for his first hedge fund
Shopify: Short Seller Andrew Left Says It's 'Dirtier Than Herbalife'
Citron Research is wrong about Cronos Group, GMP Securities says - Cantech Letter
